UK markets open in 7 hours 15 minutes
NIKKEI 225
26,393.04 -411.56 (-1.54%) HANG SENG
21,859.79 -137.10 (-0.62%) CRUDE OIL
106.06 +0.30 (+0.28%) GOLD FUTURES
1,806.30 -1.00 (-0.06%) DOW
30,775.43 -253.88 (-0.82%) BTC-GBP
15,684.14 -917.70 (-5.53%)
XOMA Corporation (0M26.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 02:30PM BST
| Previous close | 18.73 |
| Open | 17.10 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 17.10 - 17.10 |
| 52-week range | 17.10 - 17.10 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | 24.23 |
| EPS (TTM) | 1.00 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Investing in XOMA (NASDAQ:XOMA) five years ago would have delivered you a 196% gain
While XOMA Corporation ( NASDAQ:XOMA ) shareholders are probably generally happy, the stock hasn't had particularly...
- Globe Newswire
Kuros Biosciences: Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers a $5 Million Milestone Payment
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules • $2.5 million of milestone to be paid to XOMA Corporation under royalty agreement SCHLIEREN (ZURICH), Switzerland, June 02, 2022 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (“Kuros” or the “Company”), a leader in next generation bone graft technologies, notes the completion of the acquisition of Checkmate Pharmaceuticals (NASDAQ: CMPI) by Regeneron Pharmaceuticals (NASDAQ: REGN). The completion triggers a $5 million milestone paym
- Simply Wall St.
Is Weakness In XOMA Corporation (NASDAQ:XOMA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
XOMA (NASDAQ:XOMA) has had a rough three months with its share price down 13%. But if you pay close attention, you...
© 2022 Yahoo. All rights reserved.
